Hi All,

 

I would like to bring the following exciting opportunity in the Almo Lab at Albert Einstein College of Medicine to your attention:

 

We seek a post doctoral fellow with interest in the development of novel biologics for the treatment of infectious
diseases, autoimmune diseases and cancers. The successful candidate will have extensive experience in mammalian protein expression, and protein design and/or protein chemistry. We have established a highly modular platform technology for the antigen-selective
targeting of T cells, which affords the unique opportunity to expand and activate, or delete, specific disease-relevant T cell populations without global impact on the T cell repertoire. A variant of this biologic platform is currently the subject of a multi-arm
clinical trial for HPV-driven head and neck cancer and an IND has recently been approved to evaluate efficacy against Wilms’ tumors. The Initial focus of the current program is on the use of these biologics as monotherapies, and for the development of novel
CAR T cell approaches, for the eradication of HIV and CMV infections and the treatment of malignancies. Interested candidates should send a CV, including the names of at least two references to steve.almo<at>einsteinmed.edu.

 

Thanks,

Jeff

 

Jeffrey B. Bonanno, Ph.D.

Department of Biochemistry

Albert Einstein College of Medicine

1300 Morris Park Avenue

Bronx, NY 10461

off. 718-430-2452 fax. 718-430-8565

email jeffrey.bonanno@einsteinmed.org